Sun Pharma launches novel drug Kapspargo Sprinkle in US
First US FDA approved, extended-release sprinkle formulation of metoprolol succinate indicated for treatment of patients with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Merck’s Accelerator programme opens for application
The programme will take place from mid-January until April 2019 at the Merck Innovation Center in Darmstadt, Germany
Sanofi launches multiple sclerosis tab in India
Aubagio offers patients diagnosed with multiple sclerosis the efficacy and convenience of once-a-day oral treatment
Glenmark Pharmaceuticals, Harbour BioMed in agreement
To develop GBR 1302, a first-in-class bispecific antibody for treatment of HER2-Positive cancers in Greater China territory
Intas Pharmaceuticals to be first to launch Pegfilgrastim biosimilar in Europe
Pelgraz, a pegylated G-CSF Biosimilar, is the latest addition to its established portfolio of over 30 oncology treatments across…
Mankind Pharma adds KABZEND to its portfolio with Rishi Kapoor as brand ambassador
Ayurvedic-based formulation, KABZEND is produced to prevent constipation
FDA supports critical research to advance drug and biologics development
Under this programme, the FDA engages with industry early in their process of developing new technology, and helps resolve any…
Lindström India launches India’s first cleanroom unit in Pune
The staff in the unit has received special training from experts in Finland and operates under classified cleanroom environment
Ajanta Pharma Q1 net up 12 % at ₹ 106 cr
Consolidated income from operations stood at ₹ 510.99 crore for the reported quarter
Zydus Cadila gets US FDA nod for anti-bacterial drug
The medication is used to treat respiratory infections, skin infections, ear infections and sexually transmitted diseases
Aurobindo Pharma receives USFDA approval for Bivalirudin injection
The estimated market size of Bivalirudin injection is US$ 101 million for the twelve months ending May 2018 according to IQVIA
Lupin’s Mandideep facility gets approval from EDQM
The unit was inspected by EDQM during March 2018
Twin USFDA approvals for Morepen Labs’ Bulk Drugs (API) facilities
Baddi facility gets US FDA nod for bulk drug 'Atorvastatin' and Masulkhana facility for 'Montelukast'
Wockhardt sets up its first manufacturing and R&D unit in Middle East
Wockhardt inaugurates a ‘state-of-the-art’ manufacturing facility for the production and packaging of sterile dry powder injection…
Zydus Cadila gets US FDA nod to market Vardenafil tablets
The product will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad
Gujarat FDCA, bioMerieux India conducts workshop on pharmaceutical microbiology
65 drugs inspector of FDCA participated in this knowledge sharing workshop
International Women Health and Breast Cancer Conference, coming soon
The event will focus on how the health of women will overall improve the health of the world
Jubilant Life Sciences pharma revenue is at INR 1,181 crore,up by 46%
The international revenues are at INR 1,507 crore, around 72 per cent of sales
Dr Reddy’s saw a year-on-year growth of 16% in the PSAI sector
Revenues from India were at INR 6.1 billion and year-on-year growth was 30 per cent
Lupin launches generic Desoximetasone Topical Spray, 0.25% in the US
It is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older